221 related articles for article (PubMed ID: 34524165)
21. False-Positive Axillary Lymph Nodes on FDG PET/CT Resulting From COVID-19 Immunization.
Nawwar AA; Searle J; Hopkins R; Lyburn ID
Clin Nucl Med; 2021 Dec; 46(12):1004-1005. PubMed ID: 33883486
[TBL] [Abstract][Full Text] [Related]
22. Intracavernous Schwannoma Characterized With 18F-FDG, 68Ga-DOTATOC, and 18F-Choline PET.
Farce J; Lecouillard I; Carsin Nicol B; Bretonnier M; Girard A
Clin Nucl Med; 2022 Feb; 47(2):e165-e166. PubMed ID: 34661554
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management.
McIntosh LJ; Bankier AA; Vijayaraghavan GR; Licho R; Rosen MP
AJR Am J Roentgenol; 2021 Oct; 217(4):975-983. PubMed ID: 33646823
[TBL] [Abstract][Full Text] [Related]
24. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 Vaccination Manifesting as Incidental Lymph Nodal Uptake on 18F-FDG PET/CT.
Ahmed N; Muzaffar S; Binns C; Ilyas MW; Usmani S
Clin Nucl Med; 2021 May; 46(5):435-436. PubMed ID: 33661193
[TBL] [Abstract][Full Text] [Related]
26. Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on
Smith MV; Yang M
J Nucl Med Technol; 2021 Sep; 49(3):286-287. PubMed ID: 33820864
[TBL] [Abstract][Full Text] [Related]
27. Metastasis From Clear Cell Renal Cell Carcinoma Mimicking Well-Differentiated Pancreatic Neuroendocrine Tumor at 18F-FDG and 68Ga-DOTATOC PET/CT.
Guglielmo P; Pesella F; Sartorello A; El Khouzai B; Berti S; Muccioli S; Gregianin M
Clin Nucl Med; 2022 Jul; 47(7):e498-e499. PubMed ID: 35675141
[TBL] [Abstract][Full Text] [Related]
28. COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine.
Shin M; Hyun CY; Choi YH; Choi JY; Lee KH; Cho YS
Clin Nucl Med; 2021 Oct; 46(10):814-819. PubMed ID: 34115709
[TBL] [Abstract][Full Text] [Related]
29. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [
Cohen D; Krauthammer SH; Wolf I; Even-Sapir E
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1854-1863. PubMed ID: 33774684
[TBL] [Abstract][Full Text] [Related]
30. Clinical utility of
Nakamoto Y; Ishimori T; Shimizu Y; Sano K; Togashi K
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1524-1530. PubMed ID: 30847538
[TBL] [Abstract][Full Text] [Related]
31. Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid.
Lococo F; Perotti G; Cardillo G; De Waure C; Filice A; Graziano P; Rossi G; Sgarbi G; Stefanelli A; Giordano A; Granone P; Rindi G; Versari A; Rufini V
Clin Nucl Med; 2015 Mar; 40(3):e183-9. PubMed ID: 25608152
[TBL] [Abstract][Full Text] [Related]
32. Correlation of immunohistopathological expression of somatostatin receptor-2 in breast cancer and tumor detection with 68Ga-DOTATOC and 18F-FDG PET imaging in an animal model.
Chereau E; Durand L; Frati A; Prignon A; Talbot JN; Rouzier R
Anticancer Res; 2013 Aug; 33(8):3015-9. PubMed ID: 23898054
[TBL] [Abstract][Full Text] [Related]
33. The Challenge of Staging Breast Cancer With PET/CT in the Era of COVID Vaccination.
Brown AH; Shah S; Groves AM; Wan S; Malhotra A
Clin Nucl Med; 2021 Dec; 46(12):1006-1010. PubMed ID: 33795590
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination.
Eshet Y; Tau N; Alhoubani Y; Kanana N; Domachevsky L; Eifer M
Radiology; 2021 Sep; 300(3):E345-E347. PubMed ID: 33904778
[TBL] [Abstract][Full Text] [Related]
35. Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid.
Venkitaraman B; Karunanithi S; Kumar A; Khilnani GC; Kumar R
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):856-64. PubMed ID: 24435773
[TBL] [Abstract][Full Text] [Related]
36. 18F-FDG and 68Ga-DOTATOC PET/CT Findings in a Case of Abdominal Leiomyosarcoma.
Lorusso M; Angelico G; Quirino M; Scolozzi V; Calcagni ML
Clin Nucl Med; 2021 May; 46(5):e270-e272. PubMed ID: 33323743
[TBL] [Abstract][Full Text] [Related]
37. Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?
Seban RD; Champion L; Yeh R; Schwartz LH; Dercle L
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3351-3352. PubMed ID: 34164727
[No Abstract] [Full Text] [Related]
38. Subtype-Guided
Wu S; Wang Y; Li J; Zhang N; Mo M; Klimberg S; Kaklamani V; Cochet A; Shao Z; Cheng J; Liu G
Oncologist; 2020 Apr; 25(4):e626-e633. PubMed ID: 32297448
[TBL] [Abstract][Full Text] [Related]
39. The incidence and duration of COVID-19 vaccine-related reactive lymphadenopathy on
El-Sayed MS; Wechie GN; Low CS; Adesanya O; Rao N; Leung VJ
Clin Med (Lond); 2021 Nov; 21(6):e633-e638. PubMed ID: 34862224
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 vaccine as a cause for unilateral lymphadenopathy detected by 18F-FDG PET/CT in a patient affected by melanoma.
Avner M; Orevi M; Caplan N; Popovtzer A; Lotem M; Cohen JE
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2659-2660. PubMed ID: 33675368
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
